New Network Enhances Care for Bronchiectasis and NTM Lung Disease Patients
The patient care network will facilitate access to specialized care and support for individuals with bronchiectasis and NTM lung disease.
The patient care network will facilitate access to specialized care and support for individuals with bronchiectasis and NTM lung disease.
This article will present notable insights from a roundtable of pulmonologists who discuss potential solutions to improve treatment strategies for non-cystic fibrosis bronchiectasis patients.
Bronchiectasis patients with a low BMI had worse FVC % predicted and FEV1 % predicted than normal or high BMI patients with the condition.
According to research published in the Journal of Allergy and Clinical Immunology: In Practice, 62% of bronchiectasis patients suffer from chronic rhinosinusitis.
Read MoreA literature review of bronchiectasis studies concluded that its economic burden is significant but likely to be underestimated.
Read MoreMutations in genes linked to other lung diseases, specifically cystic fibrosis and primary ciliary...
Read MoreThis small study also found that current quality of life questionnaires given to these patients do...
Read MoreBronchiectasis in chronic obstructive pulmonary disease (COPD) patients is associated with a...
Read MoreCystic fibrosis is the most common cause of bronchiectasis, however, non-CF bronchiectasis affects a significant percentage of lung disease patients and the number of diagnosed cases continues to grow.
Read MoreAspergillus fumigatus may increase the risk of developing bronchiectasis in COPD patients, according to researchers publishing in the International Journal of COPD.
Read MoreOften overshadowed by asthma and COPD, hospital admissions for bronchiectasis are estimated to cost the US healthcare system as much as $1.4 billion annually.
Read MoreAlthough COPD and bronchiectasis share many of the hallmark symptoms of obstructive lung diseases, evaluation and treatment for both diseases differ, and diagnosis between the two can be a challenge.
Read MoreThere are several therapeutic techniques for airway clearance. But with all the options, how does an RT decide which is the most effective for the patient?
Read MoreOne study has shown that the common cholesterol-lowering drugs could provide relief to patients suffering from bronchiectasis, a chronic lung disease.
Read MoreTwo placebo-controlled trials found that that macrolide antibiotics azithromycin and erythromycin resulted in improvement in symptoms for patients with non-CF Bronchiectasis, but treatment could increase the risks of drug-resistance.
Read More